首页|细胞周期退出与分化蛋白1的下调与胶质瘤疾病进展及不良预后相关

细胞周期退出与分化蛋白1的下调与胶质瘤疾病进展及不良预后相关

扫码查看
目的 探究细胞周期退出与分化蛋白1(CEND1)在胶质瘤中的表达以及其对胶质瘤患者预后的影响.方法 从癌症基因组图谱(TCGA)数据库获得胶质瘤与癌旁组织中CEND1的信使RNA(mRNA)测序数据和相应的临床信息后,基于R v4.0.3分析胶质瘤样本CEND1的表达及其高低表达与胶质瘤患者预后的关系,设定P<0.05具有统计学意义.进一步采用蛋白质印迹法(Western blot)、实时定量聚合酶链反应(qPCR)与免疫组织化学法验证CEND1在共80例胶质瘤患者肿瘤样本和15例正常脑组织样本中的表达.两样本间对比采取t检验,多组间差异采用单因素方差分析.结果 TCGA公共数据库分析表明CEND1在胶质瘤中的表达低于正常组织(6.965± 1.109比7.728±1.085,t=12.37,P<0.01),CEND1在2级和3级胶质瘤中的表达量高于4级胶质瘤(7.302±1.019、7.094±1.041 比 6.197±1.007,t=10.60、8.57,P<0.01).生存分析显示CEND1高表达组的胶质瘤患者总生存期要好于CEND1低表达组[风险比(HR)=0.56,95%可信区间(CI):0.43~0.72,P<0.01].蛋白印迹法结果表明,CEND1蛋白在胶质瘤组织中的表达量,明显低于正常脑组织;随胶质瘤级别升高,CEND1蛋白的表达逐渐下降.qPCR结果表明CEND1在正常脑组织和低级别胶质瘤(1级、2级、3级)中的表达要高于高级别胶质瘤(G4组)(1.000±0.079、0.747±0.118、0.505±0.125、0.317±0.088 比 0.170±0.094,t=25.79、20.38、13.25、7.21,P<0.01).免疫组织化学法结果表明,与正常脑组织比较,CEND1蛋白在胶质瘤组织中低表达,且随胶质瘤级别的升高,其表达水平逐渐降低.结论 CEND1的下调与胶质瘤疾病进展及生存率下降明显相关.
Down-regulation of cell cycle exit and neuronal differentiation 1 in glioma:a potential indicator of tumor progression and poor prognosis
Objective To explore the expression of cell cycle exit and neuronal differentiation 1(CEND1)in glioma and its impact on the prognosis of glioma patients.Methods RNA sequencing data and corresponding clinical information for glioma and normal brain tissues were downloaded from The Canc-er Genome Atlas Program(TCGA)database.The mRNA expression of CEND1 in glioma and normal brain tissues,and the relationship between CEND1 high/low expression and prognosis of glioma patients were an-alyzed based on R V4.0.3.Western blotting,quantitative real-time polymerase chain reaction(qPCR)and immunohistochemistry(IHC)were performed to evaluate the expression of CEND1 in 80 human glioma samples and 15 human normal brain samples.The t-test was used for comparison between groups,and ANOVA was used to compare among multiple groups.Results The TCGA public database analysis showed that the expression of CEND1 in glioma was lower than in the normal tissue(6.965±1.109 vs.7.728±1.085,t=12.37,P<0.01),and CEND1 was down-regulated in grade 4 glioma compared to grade 2 and grade 3 gliomas(6.197±1.007 vs.7.302±1.019,7.094±1.041,t=10.60,8.57,P<0.01).Survival analysis showed that the overall survival of patients with glioma in CEND1 high expression group was better than CEND1 low expression group[Hazard ratio(HR)=0.56,95%confidence interval(CI):0.43-0.72,P<0.01].Western blotting indicated that the expression CEND1 protein was signifi-cantly lower in glioma tissue than normal brain tissue(NBT).Additionally,the expression of CEND1 protein decreased from grade 1 to grade 4 gliomas.The results of qPCR showed agreement with those of Western blotting(P<0.05).The results of immunohistochemistry showed that compared with NBT,the expression of CEND1 protein in glioma tissue was significantly reduced.With the increase of glioma WHO grade,the expression of CEND1 decreased.Conclusion The down-regulation of CEND1 is related to tumor progress and poor prognosis of glioma.

Cell cycle exit and neuronal differentiation 1GliomaOverall survivalPrognosis

保森、李俊俊、姜晓兵

展开 >

华中科技大学同济医学院附属协和医院神经外科,武汉 430022

细胞周期退出与分化蛋白1 胶质瘤 总生存期 预后

国家自然科学基金

82273210

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(4)
  • 6